Alps Advisors Inc Infinity Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.49 - $1.2 $45,242 - $110,798	-92,332 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $9,085 - $25,653	-10,689 Reduced 10.38%	92,332 $105,000
Q4 2021 Feb 09, 2022	SELL	$1.86 - $3.36 $10,639 - $19,219	-5,720 Reduced 5.26%	103,021 $232,000
Q3 2021 Nov 15, 2021	SELL	$1.52 - $3.82 $12,190 - $30,636	-8,020 Reduced 6.87%	108,741 $372,000
Q2 2021 Aug 11, 2021	BUY	$2.66 - $3.47 $310,584 - $405,160	116,761 New	116,761 $349,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.